Corrigendum to “Assessment of toxicity and biodistribution of recombinant AAV8 vector–mediated immunomodulatory gene therapy in mice with Pompe disease”

Benzer Materyaller

• Assessment of toxicity and biodistribution of recombinant AAV8 vector–mediated immunomodulatory gene therapy in mice with Pompe disease
  Yazar:: Wang, Gensheng, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Assessment of toxicity and biodistribution of recombinant AAV8 vector–mediated immunomodulatory gene therapy in mice with Pompe disease
  Yazar:: Wang, Gensheng, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• β2 Agonists Enhance the Efficacy of Simultaneous Enzyme Replacement Therapy in Murine Pompe Disease
  Yazar:: Koeberl, Dwight D., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Hydrostatic Isolated Limb Perfusion with Adeno-associated Virus Vectors Enhances Correction of Skeletal Muscle in Pompe Disease
  Yazar:: Sun, Baodong, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease
  Yazar:: Li, Songtao, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)